← 返回

头颈癌干细胞免疫逃逸机制

英文原题:Mechanisms of immune evasion by head and neck cancer stem cells.

查看英文原题

Mechanisms of immune evasion by head and neck cancer stem cells.

PubMed 2022/08/02(内容时间) Front Oral Health Q1 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

口腔和头颈癌干细胞(HNCSCs)驱动的免疫逃逸监视涉及不同机制。本综述的目的是展示关于HNCSCs通过免疫抑制、CSCs表型和环境信号对肿瘤逃逸的主要影响的最新认识,并重点介绍克服免疫逃逸的策略。主要结果推动了细胞表面受体及分泌产物和配体、细胞间串扰以及基因调控的参与。表达BMI1的细胞导致CD8+ T细胞募集减少和抗PD-1治疗效应降低是一个关键事件;Natural Killer细胞配体及其激活和扩增所需的细胞因子对于控制肿瘤生长和通过免疫治疗靶向CSCs至关重要;表达ALDH1的CSCs与PD-L1表达增加相关,并与DNMT3b表达呈正相关;CSCs中CD276表达可作为检查点抑制剂,并与Activator Protein 1(AP-1)激活一起,形成持续的正反馈,通过抑制CD8+ T细胞并使头颈癌中免疫细胞浸润受阻来实现免疫逃逸。这些数据表明,更好地理解HNCSCs与肿瘤微环境中免疫细胞之间的相互作用具有重要意义。最终的临床意义在于为优化靶点选择奠定基础,并改善正在进行的治疗的免疫识别以及对已批准免疫治疗的应答。

展开英文摘要原文

Different mechanisms are involved in immune escape surveillance driven by Oral and Head and Neck Cancer Stem Cells (HNCSCs). The purpose of this review is to show the most current knowledge regarding the main impact of HNCSCs on tumor evasion through immunosuppression, CSCs phenotypes and environmental signals, highlighting strategies to overcome immune evasion. The main results drive the participation of cell surface receptors and secreted products and ligands, the crosstalk between cells, and genetic regulation.

The reduction in CD8 + T cell recruitment and decreased effector of anti-PD-1 therapy by cells expressing BMI1 is a key event; Natural Killer cell ligands and cytokines needed for its activation and expansion are crucial to control tumor growth and to target CSCs by immunotherapy; CSCs expressing ALDH1 are related to increased expression of PD-L1, with a positive link between DNMT3b expression; CD276 expression in CSCs can act as a checkpoint inhibitor and together with Activator Protein 1 (AP-1) activation, they create continuous positive feedback that enables immune evasion by suppressing CD8+ T cells and prevent immune cell infiltration in head and neck cancer.

These data demonstrate the relevance of the better understanding of the interaction between HNCSCs and immune cells in the tumor microenvironment. The ultimate clinical implication is to ground the choice of optimized targets and improve immune recognition for ongoing treatments as well as the response to approved immunotherapies.

论文信息

作者
Xavier FCA、Silva JC、Rodini CO、Rodrigues MFSD
第一作者单位
Laboratory of Oral Surgical Pathology, School of Dentistry, Federal University of Bahia, Salvador, BA, Brazil.Brazil
通讯作者单位
Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University (UNINOVE), São Paulo, SP, Brazil.Brazil
文献类型
综述
期刊
Frontiers in oral health2022
原文标识
PubMed 35982868 · DOI 10.3389/froh.2022.957310